Clinical and genetic characterization of congenital hyperinsulinism in Spain.

CONTEXT Congenital hyperinsulinism (CHI) is a clinically and genetically heterogeneous disease characterized by severe hypoglycemia caused by inappropriate insulin secretion by pancreatic β-cells. OBJECTIVE To characterize clinically and genetically CHI patients in Spain. DESIGN AND METHODS We included 50 patients with CHI from Spain. Clinical information was provided by the referring clinicians. Mutational analysis was carried out for KCNJ11, ABCC8, and GCK genes. The GLUD1, HNF4A, HNF1A, UCP2, and HADH genes were sequenced depending on the clinical phenotype. RESULTS We identified the genetic etiology in 28 of the 50 CHI patients tested: 21 had a mutation in KATP channel genes (42%), three in GLUD1 (6%), and four in GCK (8%). Most mutations were found in ABCC8 (20/50). Half of these patients (10/20) were homozygous or compound heterozygous, with nine being unresponsive to diazoxide treatment. The other half had heterozygous mutations in ABCC8, six of them being unresponsive to diazoxide treatment and four being responsive to diazoxide treatment. We identified 22 different mutations in the KATP channel genes, of which ten were novel. Notably, patients with ABCC8 mutations were diagnosed earlier, with lower blood glucose levels and required higher doses of diazoxide than those without a genetic diagnosis. CONCLUSIONS Genetic analysis revealed mutations in 56% of the CHI patients. ABCC8 mutations are the most frequent cause of CHI in Spain. We found ten novel mutations in the KATP channel genes. The genetic diagnosis is more likely to be achieved in patients with onset within the first week of life and in those who fail to respond to diazoxide treatment.

[1]  Alison M. Thomas,et al.  Molecular mechanisms of congenital hyperinsulinism due to autosomal dominant mutations in ABCC8. , 2015, Human molecular genetics.

[2]  K. Hussain,et al.  Molecular mechanisms of congenital hyperinsulinism. , 2015, Journal of molecular endocrinology.

[3]  Min Zhang,et al.  Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism. , 2015, Molecular genetics and metabolism.

[4]  K. Hussain,et al.  Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy , 2014, International Journal of Pediatric Endocrinology.

[5]  M. Zenker,et al.  Clinical and Genetic Evaluation of Patients with KATP Channel Mutations from the German Registry for Congenital Hyperinsulinism , 2014, Hormone Research in Paediatrics.

[6]  H. Huopio,et al.  A Mouse Model of Human Hyperinsulinism Produced by the E1506K Mutation in the Sulphonylurea Receptor SUR1 , 2013, Diabetes.

[7]  A. Morgan,et al.  Congenital hyperinsulinism: clinical and molecular analysis of a large Italian cohort. , 2013, Gene.

[8]  A. Salvatoni,et al.  Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy , 2013, Hormone Research in Paediatrics.

[9]  Diva D. De León,et al.  Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management , 2013, International Journal of Pediatric Endocrinology.

[10]  C. Stanley,et al.  Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. , 2013, The Journal of clinical endocrinology and metabolism.

[11]  S. Ellard,et al.  Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism , 2010, European journal of endocrinology.

[12]  B. Glaser,et al.  Relative Expression of a Dominant Mutated ABCC8 Allele Determines the Clinical Manifestation of Congenital Hyperinsulinism , 2011, Diabetes.

[13]  F. Brunelle,et al.  Congenital hyperinsulinism: current trends in diagnosis and therapy , 2011, Orphanet journal of rare diseases.

[14]  S. Ellard,et al.  Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations , 2011, Diabetologia.

[15]  C. Stanley,et al.  Diazoxide-Unresponsive Congenital Hyperinsulinism in Children With Dominant Mutations of the β-Cell Sulfonylurea Receptor SUR1 , 2011, Diabetes.

[16]  S. Ellard,et al.  The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. , 2011, European journal of endocrinology.

[17]  Lucimary C. Gurgel,et al.  Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation , 2010, Pediatric diabetes.

[18]  K. Hussain.  Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus , 2010, Reviews in Endocrine and Metabolic Disorders.

[19]  Yves,et al.  ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism , 2010, Journal of Medical Genetics.

[20]  I. Rica,et al.  Familial Hyperinsulinism-Hyperammonemia Syndrome in a Family with Seizures: Case Report , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[21]  B. Glaser,et al.  Large islets, beta-cell proliferation, and a glucokinase mutation. , 2010, The New England journal of medicine.

[22]  S. Ellard,et al.  Congenital Hyperinsulinism due to a Compound Heterozygous ABCC8 Mutation with Spontaneous Resolution at Eight Weeks , 2010, Hormone Research in Paediatrics.

[23]  J. C. Aledo,et al.  Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. , 2009, Molecular endocrinology.

[24]  S. Ellard,et al.  Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations , 2009, European journal of endocrinology.

[25]  A. Molven,et al.  The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy , 2009, Clinical genetics.

[26]  S. Ellard,et al.  Hyperinsulinaemic hypoglycaemia , 2009, Archives of Disease in Childhood.

[27]  Arupa Ganguly,et al.  Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. , 2008, The Journal of clinical investigation.

[28]  A. Lezcano,et al.  Estudio transversal español de crecimiento 2008. Parte I: valores de peso y longitud en recién nacidos de 26-42 semanas de edad gestacional , 2008 .

[29]  D. Yeste Fernández,et al.  [Spanish cross-sectional growth study 2008. Part I: weight and height values in newborns of 26-42 weeks of gestational age]. , 2008, Anales de pediatria.

[30]  D. Cowley,et al.  Genotype-Phenotype Associations in Patients with Severe Hyperinsulinism of Infancy , 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[31]  Á. Carracedo,et al.  Mutation spectra of ABCC8 gene in Spanish patients with hyperinsulinism of infancy (HI) , 2006, Human mutation.

[32]  A. Eliakim,et al.  Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  H. Huopio,et al.  Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. , 2004, Diabetes.

[34]  C. Stanley,et al.  Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. , 2004, The Journal of clinical endocrinology and metabolism.

[35]  A. Hattersley,et al.  Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. , 2003, Diabetes.

[36]  C. Stanley,et al.  Histopathology of Congenital Hyperinsulinism: Retrospective Study with Genotype Correlations , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[37]  H. Huopio,et al.  A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1 , 2003, The Lancet.

[38]  B. Glaser,et al.  Compound Heterozygosity for the Common Sulfonylurea Receptor Mutations Can Cause Mild Diazoxide-Sensitive Hyperinsulinism , 2002, Clinical pediatrics.

[39]  E. Mayatepek,et al.  Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome , 2000, Human Genetics.

[40]  J. Bryan,et al.  Molecular biology of adenosine triphosphate-sensitive potassium channels. , 1999, Endocrine reviews.

[41]  C. Stanley,et al.  Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. , 1998, The New England journal of medicine.

[42]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.